搜索临床试验以:0.1%布比卡因
总计8499个结果
-
Royal Brompton & Harefield NHS Foundation TrustUniversity of Oxford未知
-
Otsuka Pharmaceutical Co., Ltd.完全的
-
National Cancer Institute (NCI)主动,不招人肺腺癌 | 肺大细胞癌 | IIIA 期肺癌非小细胞癌 AJCC v7 | 微创肺腺癌 | IIIB 期肺癌非小细胞癌 AJCC v7 | 肺鳞状细胞癌 | 肺腺鳞癌美国
-
Kristina TedroffKarolinska University Hospital; Danderyd Hospital终止
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation Trust; Royal College of Physicians完全的
-
National Institute of Allergy and Infectious Diseases...University of Pittsburgh招聘中
-
Krankenhaus Barmherzige Schwestern Linz终止
-
David M. Brown, M.D.Novartis Pharmaceuticals终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | KRAS基因突变 | 转移性恶性实体瘤 | 表皮生长因子受体基因突变 | ERBB2基因扩增 | ERBB2基因突变 | EGFR基因扩增 | ERBB3基因突变 | ERBB4基因突变美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)尚未招聘
-
Baxter Healthcare CorporationMDS Pharma Services完全的
-
Schwartzberg, Lee, M.D.Amgen完全的
-
Zealand University Hospital完全的
-
Federal University of São PauloFaculdade de Ciências Médicas da Santa Casa de São Paulo未知